(Q73378723)
Statements
Type IV phosphodiesterase inhibitor is effective in prevention and treatment of experimental crescentic glomerulonephritis (English)
F W Tam
J Smith
S Agarwal
A M Karkar
D Morel
E M Thompson
scientific article published on 01 January 2000